Clinical Research Directory
Browse clinical research sites, groups, and studies.
HRQoL Keratinocyte Carcinomas
Sponsor: University Hospital, Ghent
Summary
Rationale: Keratinocyte skin cancer is known to influence the HRQoL in a specific way. Derived utility values are required for cost-effectiveness analyses of new interventions. However there is no sensitive tool to capture HRQoL that translates into utilities available. Objective: To document the exact HRQoL in patients with in KC using the generic EQ-5D-5L questionnaire, as well as the TTO, 15D and the BaSQoL questionnaire, and to develop health utilities based on these tools. Study design: Longitudinal observational study (at time 0 and time 0 +12 months). Study population: Patients aged ≥18 years consulting a dermatologist or their GP for diagnosis, treatment or follow-up of a (pre)malignant skin lesion(s).
Official title: HRQoL and Development of Health Utilities in Patients With Keratinocyte Carcinomas
Key Details
Gender
All
Age Range
18 Years - 100 Years
Study Type
OBSERVATIONAL
Enrollment
2400
Start Date
2020-07-01
Completion Date
2025-12-31
Last Updated
2024-05-09
Healthy Volunteers
No
Interventions
questionnaires
EQ-5D-5L questionnaire questioning their overall health on five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression). In addition patients will have to fill in the generic 15D questioning 15 specific dimensions on 5 levels as well as the BaSQoL, which is a disease specific questionnaire for patients with KC. The Time-trade off task is the final question.
Locations (2)
Department of Dermatology, Ghent University Hospital
Ghent, Belgium
MC Rotterdam Department of Dermatology
Rotterdam, Netherlands